Skip to content

Clinical Risk Assessment of Cognitive Function in Systemic Autoimmune Diseases

Clinical Risk Assessment of Cognitive Function in Systemic Autoimmune Diseases

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06029335
Enrollment
400
Registered
2023-09-08
Start date
2020-09-01
Completion date
2023-08-30
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Myopathies, Inflammatory, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis

Brief summary

Objectives: Systemic autoimmune diseases are chronic diseases characterized by chronic inflammation, vasculopathy, and autoimmune phenomena. Several organ involvements are typical, including the central nervous system. Formerly published investigations emphasize a mild cognitive impairment affecting attention, memory, and complicated solution tasks. However, these symptoms significantly impact patients' routines and quality of life. The study examined the associations between cognitive impairment and clinical parameters regarding systemic autoimmune diseases. Methods: General clinical data, some serum biomarkers including CCl-18, YKL-40, COMP, VEGF, Galectin-3, and Pentraxin as well as results of functional, quality of life, and neuropsychological measures, the Mini-Mental State Examination (MMSE), the Digit Span Forward-Backward, the Trail making A, B and the Digit Symbol tests all were administered.

Interventions

None listed

Sponsors

University of Pecs
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Systemic autoimmune diseases * Healthy individuals - as controls

Exclusion criteria

* Diseases of the central nervous system * Presence of pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Mini-mental State Examination12 monthsComplex Cognitive measure
The Functional Assessment of Chronic Illness Therapy F12 monthshealth-related quality of life measure

Countries

Hungary

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026